1-10 of 10
Nathan Petty, MS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Baseline and on-Treatment Bone Marrow Microenvironments Predict Myeloma Patient Outcomes and Inform Potential Intervention Strategies

Samuel A Danziger, PhD, Mark McConnell, PhD, Jake Gockley, PhD, Mary Young, PhD, Adam Rosenthal, MS, Frank Schmitz, MD PhD, David Reiss, PhD, Phil Farmer, Cody Ashby, PhD, Michael A Bauer, PhD, Frits van Rhee, MD PhD, Faith E. Davies, MD, Maurizio Zangari, MD, Nathan Petty, MS, CCRP, Wilbert B. Copeland, PhD, Brian A. Fox, PhD, Antje Hoering, PhD, Alison Fitch, Katie Newhall, PhD, Bart Barlogie, MD PhD, Brian A Walker, PhD, Matthew Trotter, PhD, Rob Hershberg, MD PhD, Andrew Dervan, Alexander Ratushny, PhD, Gareth Morgan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1882.
https://doi.org/10.1182/blood-2018-99-113169
Published: 2018
Journal Articles

A Survey of Fusion Genes in Myeloma Identifies Kinase Domain Activation Which Could be Targeted with Available Treatments

Brian A Walker, PhD, Shweta S. Chavan, PhD, Jie He, PhD, Ruslana Tytarenko, Shan Zhong, PhD, Shayu Deshpande, PhD, Purvi Patel, Caleb K. Stein, MS, Owen W Stephens, Niels Weinhold, PhD, Nathan Petty, MS, Doug Steward, Carolina Schinke, MD, Leo Rasche, MD, Mark Bailey, MSc, Siraj Ali, Jo-Anne Vergillo, MD, Jeff Ross, MD, Vincent A. Miller, MD, Phillip J Stephens, PhD, Sharmilan Thanendrarajan, MD, Maurizio Zangari, MD, Frits van Rhee, MD PhD, Tariq I Mughal, MD, Faith E Davies, MD, Gareth J Morgan, MDPhD
Journal: Blood
Blood (2016) 128 (22): 117.
https://doi.org/10.1182/blood.V128.22.117.117
Published: 2016
Journal Articles

High Risk Myeloma Is Characterized By the Bi-Allelic Inactivation of CDKN2C and RB1

Shweta S. Chavan, PhD, Christoph Heuck, MD, Jie He, PhD, Rusiana Tytarenko, Shayu Deshpande, PhD, Purvi Patel, Mark Bailey, MSc, Caleb K. Stein, MS, Owen W Stephens, Niels Weinhold, PhD, Nathan Petty, MS, Doug Steward, Leo Rasche, MD, Michael A Bauer, PhD, Cody Ashby, PhD, Erich Allen Peterson, PhD BS, MS, Shan Zhong, PhD, Michelle Nahas, PhD, Siraj M Ali, MD PhD, Jo-Anne Vergillo, MD, Jeff Ross, MD, Vincent A. Miller, MD, Phillip J Stephens, PhD, Carolina Schinke, MD, Maurizio Zangari, MD, Frits van Rhee, MD PhD, Bart Barlogie, MD PhD, Tariq I Mughal, MD, Faith E Davies, MD, Gareth J Morgan, MD PhD, Brian A Walker, PhD
Journal: Blood
Blood (2016) 128 (22): 4416.
https://doi.org/10.1182/blood.V128.22.4416.4416
Published: 2016
Journal Articles

Next Generation Sequencing (NGS) Based Minimal Residual Disease (MRD) Testing Is Highly Predictive of Overall and Progression Free Survival in the Total Therapy Trials and Shows Different Prognostic Implications in High Vs Standard Risk Multiple Myeloma

Carolina Schinke, MD, Shayu Deshpande, PhD, Hongwei Wang, Victoria Carlton, PhD, Katherine A. Kong, PhD, Martin Moorhead, PhD, Tom Willis, Purvi Patel, Sharmilan Thanendrarajan, MD, Meera Mohan, MD, Pankaj Mathur, MD, Sandra Susanibar, MD, Shadiqul Hoque, MD, Muthukumar Radhakrishnan, MD, Ruslana Tytarenko, Owen W Stephens, Leo Rasche, MD, Frits van Rhee, MD PhD, Maurizio Zangari, MD, Nathan Petty, MS, Daisy V. Alapat, MD, Sarah K. Johnson, PhD, Joshua Epstein, DSc, Bart Barlogie, MD PhD, Faith E Davies, MD, Antje Hoering, PhD, Niels Weinhold, PhD, Gareth J Morgan, MD PhD
Journal: Blood
Blood (2016) 128 (22): 2064.
https://doi.org/10.1182/blood.V128.22.2064.2064
Published: 2016
Journal Articles

Impact of Minimal Residual Disease in High and Standard Risk Multiple Myeloma

Carolina Schinke, MD, Shayu Deshpande, PhD, Alan Mitchell, Malek Faham, Purvi Patel, Sharmilan Thanendrarajan, MD, Meera Mohan, Pankaj Mathur, Aasiya Matin, Muthukumar Radhakrishnan, Ruslana Tytarenko, Owen W Stephens, PhD, Frits van Rhee, MD PhD, Maurizio Zangari, MD, Yogesh Jethava, MD, Nathan Petty, MS, Daisy V. Alapat, MD, Sarah K. Johnson, PhD, Joshua Epstein, DSc, Bart Barlogie, MD PhD, Faith E Davies, MD, Christoph Heuck, MD, Antje Hoering, Niels Weinhold, PhD, Gareth J Morgan, MDPhD
Journal: Blood
Blood (2015) 126 (23): 2979.
https://doi.org/10.1182/blood.V126.23.2979.2979
Published: 2015
Journal Articles

Assessment of Total Lesion Glycolysis and Metabolic Tumor Volume Improve the Clinical Value of Focal Lesion Assessment By FDG PET/CT in Myeloma

James E McDonald, Marcus M Kessler, Michael Gardner, Amy Buros, PhD, Sarah Waheed, MD, James Ntambi, Frits van Rhee, MD PhD, Maurizio Zangari, MD, Christoph Heuck, MD, Nathan Petty, MS, Carolina Schinke, MD, Sharmilan Thanendrarajan, MD, Alan Mitchell, Antje Hoering, Bart Barlogie, MD PhD, Gareth J Morgan, MD PhD, Faith E Davies, MD
Journal: Blood
Blood (2015) 126 (23): 724.
https://doi.org/10.1182/blood.V126.23.724.724
Published: 2015
Journal Articles

Extending Metronomic Therapy to 28 Days (metro28) for Relapsed Refractory Multiple Myeloma (RRMM)

Xenofon Papanikolaou, MD, Carolina Schinke, MD, Sharmilan Thanendrarajan, MD, Adam Rosenthal, Nathan Petty, MS, Maurizio Zangari, MD, Christoph Heuck, MD, Frits van Rhee, MD PhD, Joshua Epstein, DSc, Shmuel Yaccoby, PhD, Gareth J Morgan, MDPhD, Faith E Davies, MD, Bart Barlogie, MD PhD
Journal: Blood
Blood (2015) 126 (23): 5395.
https://doi.org/10.1182/blood.V126.23.5395.5395
Published: 2015
Journal Articles

Outcomes of Autologous Transplantation for Treatment-Related AML and MDS in Previously Treated Multiple Myeloma Patients (pts)

Shebli Atrash, Bart Barlogie, MD PhD, Maurizio Zangari, MD, Frits van Rhee, MD PhD, Sarah Waheed, MD, Clyde Bailey, Nathan Petty, MS, Christoph Heuck, MD, Gareth J Morgan, MDPhD, Yogesh Jethava, MD
Journal: Blood
Blood (2015) 126 (23): 1997.
https://doi.org/10.1182/blood.V126.23.1997.1997
Published: 2015
Journal Articles

A Prognostic 51-Gene Signature Linked to Abnormal Metaphase Cytogenetics Identifies Myeloma Patients Who Benefit from Fractionated Melphalan Dosing and Added Bortezomib, Thalidomide and Dexamethasone As Conditioning for Autologous Stem Cell Transplant

Frits van Rhee, MD PhD, Alan Mitchell, Maurizio Zangari, MD, Jeffery Sawyer, Sarah Waheed, MD, Rashid Z Khan, MD, Christoph Heuck, MD, Sharmilan Thanendrarajan, MD, Carolina Schinke, MD, Yogesh Jethava, MD, Xenofon Papanikolaou, MD, Monica Grazziutti, Nathan Petty, MS, Douglas Steward, Susan Panozzo, Clyde Bailey, Antje Hoering, John Crowley, PhD, Faith E Davies, MD, Bart Barlogie, MD PhD, Gareth J Morgan, MDPhD
Journal: Blood
Blood (2015) 126 (23): 3181.
https://doi.org/10.1182/blood.V126.23.3181.3181
Published: 2015
Journal Articles

The Impact of Combination Chemotherapy and Tandem Stem Cell Transplant on Clonal Substructure and Mutational Pattern at Relapse of MM

Christoph Heuck, MD, Niels Weinhold, PhD, Erich Allen Peterson, PhD BS, MS, Michael Bauer, Caleb K. Stein, MS, Timothy Ashby, Shweta S. Chavan, PhD, Ruslana Tytarenko, Owen W Stephens, PhD, Tobias Meissner, Donald Johann, MD MS, Frits van Rhee, MD PhD, Sarah Waheed, MD, Sarah K. Johnson, PhD, Maurizio Zangari, MD, Aasiya Matin, Nathan Petty, MS, Shmuel Yaccoby, PhD, Faith E Davies, MD, Joshua Epstein, DSc, Bart Barlogie, MD PhD, Gareth J Morgan, MDPhD
Journal: Blood
Blood (2015) 126 (23): 372.
https://doi.org/10.1182/blood.V126.23.372.372
Published: 2015